Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379380 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
An SAR study around the mixed 5-HT1ABD receptor antagonist SB-272183 found that introduction of cis-2,6-dimethyl substitution onto the piperazine ring was a key structural change, which imparted a combination of both excellent selectivity over the 5-HT1A and 5-HT1D receptors and low intrinsic activity. This led to the identification of the selective 5-HT1B receptor antagonist SB-616234.
Graphical abstractIntroduction of cis-2,6-dimethyl substitution onto the piperazine ring of a mixed 5-HT1ABD receptor antagonist offers a combination of both excellent selectivity over 5-HT1A and 5-HT1D receptors and low intrinsic activity.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Paul A. Wyman, Howard R. Marshall, Sean T. Flynn, Ron J. King, Mervyn Thompson, Paul W. Smith, Michael S. Hadley, Gary W. Price, Claire M. Scott, Lee A. Dawson,